In a bind: a quality improvement project for reducing fluoroquinolones drug–drug interactions with multivalent cations

Read full text Summarise with VIRAT
Authors: Emily A Siegrist, Steven Pan, Maria Alkozah, Danh C. Doan, Bryan Pinckney White
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Introduction Fluoroquinolone (FQ) co-administration with multivalent cations can decrease the bioavailability of the FQ significantly. This interaction is an independent risk factor for FQ resistance, which is a concern as more clinical trials and guidelines support routine use of oral antimicrobials. Methods We examined the incidence of FQ drug–drug interactions (DDIs) in a quality improvement study after implementation of a bundle of interventions including nursing education, updated medication administration record (MAR) comments and new administration times. Results In the subgroup of patients (n = 101) who had a multivalent cation administered on the same day as a FQ, co-administration within 2 hours of the FQ was higher in the pre-intervention group as compared to the post-intervention group (62% versus 22%, P < 0.001). Conclusion The bundle of interventions decreased but did not eliminate the interaction. With the interaction as an independent risk factor for resistance and increasing use of oral antibiotics, stewardship programmes should consider implementing similar interventions.

Fields of Study & Subjects

Antibiotic Use and Resistance Pharmaceutical Practices and Patient Outcomes Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
JAC-Antimicrobial Resistance
Volume
8
Issue
2
Pages
dlag037–dlag037
Publication date
9 March 2026
Language
EN